Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Preventing Language Decline in Dementia

NCT02541097 is registered in ClinicalTrials.gov with Baycrest as lead sponsor.

NCT NCT02541097
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02541097 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Preventing Language Decline in Dementia
Lead sponsor
Baycrest
Phase
Not applicable
Overall status
Completed
Start date
May 31, 2016
Completion date
January 31, 2019
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary progressive aphasia